• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> REGISTER for our free GMP Newsletter LOGFILE

Image

TOP 5 GMP Downloads

1. GDP Audit Checklist
More than 700 questions with reference to regulations for preparing and carrying out GDP audits.

 

2. GMP Audit Checklist
The GMP Audit Checklist works great for both sides - the auditor and the inspected company.

 

3. Quality Agreement
Defines framework conditions and processes between contract givers and contract acceptors in order to meet mandatory quality criteria.

 

4. Risk Management
Apart from factual content you will find many tables, examples, forms, which can be used in daily practice.

 

5. Documenting Process Validation – A Drugmaker’s Guide
Document process validation in a way that’s sure to satisfy – and impress – regulators.

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to find more Downloads!

News about GMP/cGMP

2009-07-13

EMEA published Annual Report 2008

The European Medicines Agency has published its annual report for 2008, a highly productive year in which the Agency consolidated its work in core activity areas and made good progress with many of the initiatives it is involved in.

 

"The year 2008 was one of consolidation and steady progress for the European Medicines Agency (EMEA), rather than one of major leaps and bounds.

However, set against a background of continuing globalisation of the pharmaceutical sector, further
rapid advances in medical science and the unrelenting pace of regulatory activity in the medicines
network of the European Union (EU), it was by no means a ‘dull’ year for the Agency.
As pharmaceutical development and clinical trials of medicines move increasingly beyond the
traditional spheres of Europe and North America, regulators are becoming more keenly aware of the
need for international cooperation on ensuring that safe and ethical practices are being used for the
development and testing of medicinal products in all parts of the world. In 2008, the Agency intensified
its cooperation with international partners to ensure its contribution to global efforts for safer and better
medicines around the world.

However, set against a background of continuing globalisation of the pharmaceutical sector, further rapid advances in medical science and the unrelenting pace of regulatory activity in the medicines network of the European Union (EU), it was by no means a ‘dull’ year for the Agency.

As pharmaceutical development and clinical trials of medicines move increasingly beyond the traditional spheres of Europe and North America, regulators are becoming more keenly aware of the need for international cooperation on ensuring that safe and ethical practices are being used for the development and testing of medicinal products in all parts of the world. In 2008, the Agency intensified its cooperation with international partners to ensure its contribution to global efforts for safer and better medicines around the world. [...]"

Source: Summary of the European Medicines Agency’s annual report for 2008, EMEA, 2009, EMEA/362115/2009

Annual report Summary (17 pages)

Annual report ful (158 pages)

 

Comments
No comment has yet been written about this news.